机译:LC3B PUDCTA和HMGB1表达的综合评价预测乳腺癌辅助化疗后复发的残留风险
Georges Francois Leclerc Ctr Dept Med Oncol Dijon France;
Ctr Jean Perrin EA 4677 Clermont Ferrand France;
Ctr Rech Cordeliers Equipe Labellisee Ligue Natl Canc 11 Paris France;
Ctr Georges Francois Leclerc Biostat &
Epidemiol Unit EA 4184 Dijon France;
Gustave Roussy Canc Campus Metabol &
Cell Biol Platforms Villejuif France;
Inst Gustave Roussy INSERM Equipe Labellisee Ligue Natl Canc U1015 F-94805 Villejuif France;
Inst Gustave Roussy INSERM Equipe Labellisee Ligue Natl Canc U1015 F-94805 Villejuif France;
Inst Gustave Roussy INSERM Equipe Labellisee Ligue Natl Canc U1015 F-94805 Villejuif France;
Ctr Rech Cordeliers Equipe Labellisee Ligue Natl Canc 11 Paris France;
Georges Francois Leclerc Ctr Dept Pathol &
Tumor Biol Dijon France;
Georges Francois Leclerc Ctr Dept Med Oncol Dijon France;
Georges Francois Leclerc Ctr Dept Med Oncol Dijon France;
Inst Gustave Roussy Dept Med Oncol Villejuif France;
Inst Gustave Roussy Dept Med Oncol Villejuif France;
Ctr Georges Francois Leclerc Biostat &
Epidemiol Unit EA 4184 Dijon France;
Ctr Georges Francois Leclerc Biostat &
Epidemiol Unit EA 4184 Dijon France;
Inst Gustave Roussy INSERM Identificat Mol Predictors &
New Targets Canc Tre F-94805 Villejuif;
Inst Gustave Roussy Dept Med Oncol Villejuif France;
Inst Gustave Roussy INSERM Equipe Labellisee Ligue Natl Canc U1015 F-94805 Villejuif France;
Gustave Roussy Canc Campus Metabol &
Cell Biol Platforms Villejuif France;
breast cancer; histology; HMGB1; LC3; pathology; prognostic; tumor microarray;
机译:LC3B PUDCTA和HMGB1表达的综合评价预测乳腺癌辅助化疗后复发的残留风险
机译:用对比增强光谱乳房X线检查预测对新辅助化疗的反应和乳腺癌残留疾病评估:一种定性和定量方法
机译:术后血清蛋白质组学特征可能预测接受辅助化疗的高危原发性乳腺癌患者的转移性复发
机译:新辅助化疗治疗前乳腺癌复发多峰预测
机译:结合生物标志物和临床病理因素预测乳腺癌对辅助化疗的反应:Cox模型和支持向量机(SVM)方法。
机译:LC3B点和HMGB1表达的联合评估预测乳腺癌辅助化疗后复发的残留风险
机译:Shon表达预测蒽曲素的组合化疗或三莫昔芬治疗后乳腺癌患者的反应和复发风险